Avesta76
1 known investors
Find your way into Avesta76
Sign up to see every warm intro you have to Avesta76
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Avesta76 team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Avesta Bio is a biotech company developing cancer therapeutics by targeting oxidative stress and its role in disease, based on the approach of identifying what is common across cancer cells rather than what differs. Its research points to methods of killing many cancer cell types without harming normal cells, with potential applications to other metabolic diseases.
Investors · 1
Funding
SEC filings, press & company announcements- Undisclosed amountSEEDNov 2023Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Frequently asked questions
- What does Avesta76 do?
- Avesta Bio is a biotech company developing cancer therapeutics by targeting oxidative stress and its role in disease, based on the approach of identifying what is common across cancer cells rather than what differs. Its research points to methods of killing many cancer cell types without harming normal cells, with potential applications to other metabolic diseases.
- Who are Avesta76's investors?
- Avesta76's investors include Cancer Fund.